Literature DB >> 21824948

Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial.

Toshikazu Saito1, Makoto Watanabe, Junko Nishida, Tomono Izumi, Masao Omura, Toshikazu Takagi, Ryuzo Fukunaga, Yasutsugu Bandai, Naoko Tajima, Yosikazu Nakamura, Masaharu Ito.   

Abstract

BACKGROUND: Previous studies demonstrated that intensive lifestyle modification can prevent type 2 diabetes mellitus among those with impaired glucose tolerance, but similar beneficial results have not been proved among those with impaired fasting glucose levels. We investigated the efficacy of lifestyle modification on type 2 diabetes incidence among those with impaired fasting glucose levels.
METHODS: The present study was an unmasked, multicenter, randomized, controlled trial. A total of 641 overweight Japanese (aged 30-60 years) with impaired fasting glucose levels were recruited nationwide in Japan and randomly assigned to a frequent intervention group (n = 311) or a control group (n = 330). For 36 months after randomization, the frequent intervention group received individual instructions and follow-up support for lifestyle modification from the medical staff 9 times. The control group received similar individual instructions 4 times at 12-month intervals during the same period. The primary outcome was type 2 diabetes incidence in annual 75-g oral glucose tolerance tests, diagnosed according to World Health Organization criteria.
RESULTS: There were no significant differences between the allocation groups in baseline characteristics and dropout rates. Estimated cumulative incidences of type 2 diabetes were 12.2% in the frequent intervention group and 16.6% in the control group. Overall, the adjusted hazard ratio in the frequent intervention group was 0.56 (95% confidence interval, 0.36-0.87). In the post hoc subgroup analyses, the hazard ratio reduced to 0.41 (95% confidence interval, 0.24-0.69) among participants with impaired glucose tolerance at baseline, and to 0.24 (0.12-0.48) among those with baseline hemoglobin A(1c) levels of 5.6% or more (the Japan Diabetes Society method). Such risk reduction was not observed among those with isolated impaired fasting glucose findings or baseline hemoglobin A(1c) levels of less than 5.6%.
CONCLUSIONS: Lifestyle modifications can prevent type 2 diabetes among overweight Japanese with impaired fasting glucose levels. In addition, identifying individuals with more deteriorated glycemic status by using 75-g oral glucose tolerance test findings or, especially, measurement of hemoglobin A(1c) levels, could enhance the efficacy of lifestyle modifications. TRIAL REGISTRATION: umin.ac.jp/ctr Identifier: UMIN000001959.

Entities:  

Mesh:

Year:  2011        PMID: 21824948     DOI: 10.1001/archinternmed.2011.275

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  96 in total

Review 1.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

Review 2.  Treatment of prediabetes.

Authors:  Mustafa Kanat; Ralph A DeFronzo; Muhammad A Abdul-Ghani
Journal:  World J Diabetes       Date:  2015-09-25

3.  Strategies for preventing type 2 diabetes: an update for clinicians.

Authors:  Kaivan Khavandi; Halima Amer; Bashar Ibrahim; Jack Brownrigg
Journal:  Ther Adv Chronic Dis       Date:  2013-09       Impact factor: 5.091

Review 4.  Japanese Clinical Practice Guideline for Diabetes 2016.

Authors:  Masakazu Haneda; Mitsuhiko Noda; Hideki Origasa; Hiroshi Noto; Daisuke Yabe; Yukihiro Fujita; Atsushi Goto; Tatsuya Kondo; Eiichi Araki
Journal:  Diabetol Int       Date:  2018-03-27

5.  Estimating insulin sensitivity and beta cell function: perspectives from the modern pandemics of obesity and type 2 diabetes.

Authors:  J J Nolan; K Færch
Journal:  Diabetologia       Date:  2012-08-22       Impact factor: 10.122

6.  How can we identify candidates at highest risk--to screen or not to screen?

Authors:  N C Barengo; J O Tuomilehto
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

Review 7.  Prediabetes diagnosis and treatment: A review.

Authors:  Nidhi Bansal
Journal:  World J Diabetes       Date:  2015-03-15

8.  Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.

Authors:  Sun H Kim; Alice Liu; Danit Ariel; Fahim Abbasi; Cindy Lamendola; Kaylene Grove; Vanessa Tomasso; Gerald Reaven
Journal:  Diabetologia       Date:  2013-12-11       Impact factor: 10.122

Review 9.  Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.

Authors:  Matthew D Campbell; Thirunavukkarasu Sathish; Paul Z Zimmet; Kavumpurathu R Thankappan; Brian Oldenburg; David R Owens; Jonathan E Shaw; Robyn J Tapp
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

Review 10.  Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  J Sonya Haw; Karla I Galaviz; Audrey N Straus; Alysse J Kowalski; Matthew J Magee; Mary Beth Weber; Jingkai Wei; K M Venkat Narayan; Mohammed K Ali
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.